Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2012
02/29/2012EP2423196A1 5, 6 or 7-substituted-3-phenylisoquinolinamine derivatives and therapeutic use thereof
02/29/2012EP2423194A1 NOVEL THYROID HORMONE beta RECEPTOR AGONIST
02/29/2012EP2423190A1 Compounds Exhibiting PGD 2 Receptor Antagonism
02/29/2012EP2422788A2 Benzodiazepines and compositions and uses thereof
02/29/2012EP2421852A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
02/29/2012EP2421851A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
02/29/2012EP2421850A1 3 -azabicyclo [4.1.0]heptanes used as orexin antagonists
02/29/2012EP2421849A1 Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
02/29/2012EP2421848A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
02/29/2012EP2421847A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
02/29/2012EP2421846A1 5-alkynyl-pyridines
02/29/2012EP2421845A1 Antiviral compounds and uses thereof
02/29/2012EP2421837A1 Preparation of c-pyrazine-methylamines
02/29/2012EP2421827A2 Process for the preparation of 4-(3-chloro-2-fluoro- anilino)-7-methoxy-6- { [1-(n-methylcarbamoylmethyl)- piperidin- 4-yl]oxy}quinazoline
02/29/2012EP2421826A1 Proline derivatives as cathepsin inhibitors
02/29/2012EP2421825A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
02/29/2012EP2421824A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
02/29/2012EP2421823A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
02/29/2012EP2421537A1 Pyrazolylaminopyridines as inhibitors of fak
02/29/2012EP2323980B1 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases
02/29/2012EP2170066B1 Pesticides and uses thereof
02/29/2012EP2049116B1 Hepatitis c virus inhibitors
02/29/2012EP1953148B1 Heterocyclic amide compound and use thereof
02/29/2012EP1840171B1 Anthrapyridone compound, magenta ink composition and colored matter
02/29/2012EP1669350B1 Piperidine derivatives
02/29/2012CN102365276A Substituted spiro-amide compounds
02/29/2012CN102365275A Carboxamide compounds and methods for using the same
02/29/2012CN102365271A Heterocyclic compounds as autotaxin inhibitors
02/29/2012CN101967129B Preparation method of 4-aryl-1H-1, 2, 3-triazole
02/29/2012CN101400659B Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
02/29/2012CN101208328B Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
02/28/2012US8124780 Benzimidazole compound
02/28/2012US8124779 Dissolving base addition salt of esomeprazole in water containing at least one amine, adding at least one acid, allowing esomeprazole non-salt form to crystallize and isolating the formed crystals; for treatment of gastrointestinal disorders
02/28/2012US8124768 4-pyridinone compounds and their use for cancer
02/28/2012US8124766 Inhibitors of diacylglycerol acyltransferase
02/28/2012US8124765 Synthesis of 4/5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine
02/28/2012US8124764 Fused heterocyclyc inhibitor compounds
02/28/2012US8124763 Process for the synthesis of 5-(methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzeneamine
02/28/2012US8124759 Inhibitors of protein kinases
02/28/2012US8124647 Non-steroidal androgens compounds
02/28/2012US8124641 Aminotetrahydroindazoloacetic acids
02/28/2012US8124628 Diaryl substituted alkanes
02/28/2012US8124627 Biphenyl compounds useful as muscarinic receptor antagonists
02/28/2012US8124626 Methods of treating inflammations and infections with pyridinium salts
02/28/2012US8124625 Method of enhancing the expression of apolipoprotein AI using olefin derivatives
02/28/2012US8124624 Substituted sulfonamide compounds
02/28/2012US8124613 Spirotropane compounds
02/28/2012US8124611 Inhibitors of the mutant form of kit
02/28/2012US8124604 Inhibitors of bruton's tyrosine kinase
02/28/2012US8124602 Compounds for the treatment of multi-drug resistant bacterial infections
02/23/2012WO2012024670A2 Composition and methods for treating glioblastoma
02/23/2012WO2012024620A2 Autotaxin inhibitors and uses thereof
02/23/2012WO2012024419A2 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
02/23/2012WO2012024373A1 Compounds for the treatment of hepatitis c
02/23/2012WO2012024132A2 Solution-processable electron-transport materials and related organic optoelectronic devices
02/23/2012WO2012023947A1 Bicarbazole compounds for oleds
02/23/2012WO2012023143A1 Fungicidal pyrazoles
02/23/2012WO2012022795A1 Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin b1 receptor
02/23/2012WO2012022487A1 Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor
02/23/2012WO2012022408A1 Pyrimidine derivatives as fak inhibitors
02/23/2012WO2012022265A1 Pyrrolopyrimidine compounds and uses thereof
02/23/2012WO2012022217A1 N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)phenyl]benzamide derivatives, a preparation method and use for synthesis of imatinib thereof
02/23/2012WO2012022120A1 Dihydropyrazole compounds
02/23/2012WO2012022045A1 Pyrrolopyrimidine compounds and uses thereof
02/23/2012WO2012021974A1 Compositions and methods for treatment of cystic fibrosis and diseases associated with aberrant protein cellular processing
02/23/2012WO2012003405A4 Sgc stimulators
02/23/2012WO2011126903A3 Multisubstituted aromatic compounds as inhibitors of thrombin
02/23/2012WO2011119894A3 Heterocyclic compounds useful for kinase inhibition
02/23/2012US20120046467 Quaternary ammonium salt compounds
02/23/2012US20120046463 Process for the Preparation of Imatinib Base
02/23/2012US20120046319 Process for the preparation of enantiomerically enriched proton pump inhibitors
02/23/2012US20120046316 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
02/23/2012US20120046315 Intermediate and oral administrative formats containing lenalidomide
02/23/2012US20120046308 Novel alpha-phenoxybenzeneacetic acid derivative and pharmaceutical preparation comprising same
02/23/2012US20120046301 Substituted Cyclic Carboxamide and Urea Derivatives as Ligands of the Vanilloid Receptor
02/23/2012US20120046300 Quinazoline Derivatives as Angiogenesis Inhibitors
02/23/2012US20120046289 Pyridazine Carboxamide Orexin Receptor Antagonists
02/23/2012US20120046285 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
02/23/2012US20120046280 Novel heteropyrrole analogs acting on cannabinoid receptors
02/23/2012US20120046276 Tuberculosis treatment using pleuromutilin derivatives
02/23/2012US20120046275 Cytoskeletal active rho kinase inhibitor compounds, composition and use
02/23/2012US20120046274 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
02/23/2012US20120046269 Novel Amino Azaheterocyclic Carboxamides
02/23/2012US20120046268 Substituted piperidines as Par-1 Antagonists
02/23/2012US20120046250 Methods and compositions useful in treating cancer and reducing wnt mediated effects in a cell
02/23/2012US20120046246 Methods for treating osteoclast-related disease, compounds and compositions thereof
02/23/2012US20120045509 Modified release compositions for dpp-iv inhibitors
02/23/2012US20120045470 Imatinib immunoassay
02/23/2012US20120045454 2,4-pyrimidinediamine compounds and their uses
02/23/2012CA2808866A1 Compositions and methods for treatment of cystic fibrosis and diseases associated with aberrant protein cellular processing
02/23/2012CA2808543A1 Pyrrolopyrimidine compounds and uses thereof
02/23/2012CA2808540A1 Pyrimidine derivatives as fak inhibitors
02/23/2012CA2806634A1 Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor
02/22/2012EP2420501A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
02/22/2012EP2420500A1 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
02/22/2012EP2420499A1 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position as potent PARP inhibitors
02/22/2012EP2420498A1 5-substituted quinazolinone derivatives as anti-cancer agents
02/22/2012EP2420497A1 5-substituted quinazolinone derivatives as anti-cancer agents
02/22/2012EP2420491A1 3 , 5-substitued piperidine compounds as renin inhibitors
02/22/2012EP2419420A1 Indole derivative modulators of the alpha 7 nachr
1 ... 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 ... 1080